(BYND) Beyond Meat - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US08862E1091
Stock: Burgers, Sausages, Ground Meat, Nuggets, Patties
Total Rating 13
Risk 43
Buy Signal -0.65
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 95.5% |
| Relative Tail Risk | -21.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -99.12 |
| Character TTM | |
|---|---|
| Beta | 1.200 |
| Beta Downside | 2.138 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.25% |
| CAGR/Max DD | -0.66 |
Description: BYND Beyond Meat January 01, 2026
Beyond Meat, Inc. (NASDAQ: BYND) develops, manufactures, markets, and sells plant-based meat alternatives that mimic beef, pork, and poultry under the “Beyond” brand, distributing through grocery, mass-merchant, club, natural-retailer, restaurant, food-service, and school channels in the U.S. and abroad. The company, originally incorporated as Savage River, Inc. in 2008, rebranded to Beyond Meat in September 2018 and is headquartered in El Segundo, California.
Key recent metrics: FY 2023 revenue reached roughly $1.3 billion, a 12 % YoY increase, but the firm posted a net loss of $210 million, reflecting high R&D and marketing spend. The plant-based protein market is projected to grow at a CAGR of ~10 % through 2028, driven by rising consumer health awareness and sustainability concerns. Strategic partnerships-most notably the 2023 supply agreement with McDonald’s and a 2022 joint venture with PepsiCo’s snack division-provide exposure to both food-away-from-home and packaged-snack segments, potentially expanding BYND’s addressable market.
For a deeper, data-driven look at BYND’s valuation and risk profile, consider exploring the analyst tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -237.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.24 > 0.02 and ΔFCF/TA -8.68 > 1.0 |
| NWC/Revenue: 77.43% < 20% (prev 65.17%; Δ 12.26% < -1%) |
| CFO/TA -0.21 > 3% & CFO -127.1m > Net Income -237.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.5m) vs 12m ago 17.51% < -2% |
| Gross Margin: 9.62% > 18% (prev 0.06%; Δ 956.5% > 0.5%) |
| Asset Turnover: 44.96% > 50% (prev 46.68%; Δ -1.72% > 0%) |
| Interest Coverage Ratio: -15.51 > 6 (EBITDA TTM -196.3m / Interest Expense TTM 14.5m) |
Altman Z'' -8.77
| A: 0.38 (Total Current Assets 288.6m - Total Current Liabilities 63.6m) / Total Assets 599.7m |
| B: -2.39 (Retained Earnings -1.43b / Total Assets 599.7m) |
| C: -0.35 (EBIT TTM -225.2m / Avg Total Assets 646.3m) |
| D: -1.04 (Book Value of Equity -1.44b / Total Liabilities 1.38b) |
| Altman-Z'' Score: -8.77 = D |
Beneish M -3.88
| DSRI: 0.90 (Receivables 27.9m/34.7m, Revenue 290.6m/323.5m) |
| GMI: 0.61 (GM 9.62% / 5.92%) |
| AQI: 0.73 (AQ_t 0.09 / AQ_t-1 0.12) |
| SGI: 0.90 (Revenue 290.6m / 323.5m) |
| TATA: -0.18 (NI -237.7m - CFO -127.1m) / TA 599.7m) |
| Beneish M-Score: -3.88 (Cap -4..+1) = AAA |
What is the price of BYND shares?
As of February 08, 2026, the stock is trading at USD 0.73 with a total of 30,919,318 shares traded.
Over the past week, the price has changed by -4.49%, over one month by -21.96%, over three months by -38.75% and over the past year by -81.45%.
Over the past week, the price has changed by -4.49%, over one month by -21.96%, over three months by -38.75% and over the past year by -81.45%.
Is BYND a buy, sell or hold?
Beyond Meat has received a consensus analysts rating of 2.20.
Therefor, it is recommend to sell BYND.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 2
- StrongSell: 3
What are the forecasts/targets for the BYND price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1.6 | 120.5% |
| Analysts Target Price | 1.6 | 120.5% |
| ValueRay Target Price | 0.4 | -47.9% |
BYND Fundamental Data Overview February 03, 2026
P/E Forward = 5000.0
P/S = 1.1914
P/B = 59.3234
P/EG = 40.7473
Revenue TTM = 290.6m USD
EBIT TTM = -225.2m USD
EBITDA TTM = -196.3m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 1.54b USD (346.2m + Debt 1.31b - CCE 117.3m)
Interest Coverage Ratio = -15.51 (Ebit TTM -225.2m / Interest Expense TTM 14.5m)
EV/FCF = -10.78x (Enterprise Value 1.54b / FCF TTM -142.9m)
FCF Yield = -9.28% (FCF TTM -142.9m / Enterprise Value 1.54b)
FCF Margin = -49.18% (FCF TTM -142.9m / Revenue TTM 290.6m)
Net Margin = -81.81% (Net Income TTM -237.7m / Revenue TTM 290.6m)
Gross Margin = 9.62% ((Revenue TTM 290.6m - Cost of Revenue TTM 262.6m) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 13.73%)
Tobins Q-Ratio = 2.57 (Enterprise Value 1.54b / Total Assets 599.7m)
Interest Expense / Debt = 0.80% (Interest Expense 10.5m / Debt 1.31b)
Taxrate = 21.0% (US default 21%)
NOPAT = -177.9m (EBIT -225.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.54 (Total Current Assets 288.6m / Total Current Liabilities 63.6m)
Debt / Equity = -1.67 (negative equity) (Debt 1.31b / totalStockholderEquity, last quarter -784.1m)
Debt / EBITDA = -6.08 (negative EBITDA) (Net Debt 1.19b / EBITDA -196.3m)
Debt / FCF = -8.36 (negative FCF - burning cash) (Net Debt 1.19b / FCF TTM -142.9m)
Total Stockholder Equity = -678.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -36.78% (Net Income -237.7m / Total Assets 599.7m)
RoE = 35.06% (negative equity) (Net Income TTM -237.7m / Total Stockholder Equity -678.0m)
RoCE = -40.29% (EBIT -225.2m / Capital Employed (Equity -678.0m + L.T.Debt 1.24b))
RoIC = -35.53% (negative operating profit) (NOPAT -177.9m / Invested Capital 500.8m)
WACC = 2.66% (E(346.2m)/V(1.66b) * Re(10.34%) + D(1.31b)/V(1.66b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
Fair Price DCF = unknown (Cash Flow -142.9m)
EPS Correlation: 92.22 | EPS CAGR: 113.6% | SUE: 1.61 | # QB: 1
Revenue Correlation: -71.01 | Revenue CAGR: -9.16% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.09 | Chg30d=+0.308 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.48 | Chg30d=+0.922 | Revisions Net=+4 | Growth EPS=+55.5% | Growth Revenue=-1.5%
P/S = 1.1914
P/B = 59.3234
P/EG = 40.7473
Revenue TTM = 290.6m USD
EBIT TTM = -225.2m USD
EBITDA TTM = -196.3m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 1.54b USD (346.2m + Debt 1.31b - CCE 117.3m)
Interest Coverage Ratio = -15.51 (Ebit TTM -225.2m / Interest Expense TTM 14.5m)
EV/FCF = -10.78x (Enterprise Value 1.54b / FCF TTM -142.9m)
FCF Yield = -9.28% (FCF TTM -142.9m / Enterprise Value 1.54b)
FCF Margin = -49.18% (FCF TTM -142.9m / Revenue TTM 290.6m)
Net Margin = -81.81% (Net Income TTM -237.7m / Revenue TTM 290.6m)
Gross Margin = 9.62% ((Revenue TTM 290.6m - Cost of Revenue TTM 262.6m) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 13.73%)
Tobins Q-Ratio = 2.57 (Enterprise Value 1.54b / Total Assets 599.7m)
Interest Expense / Debt = 0.80% (Interest Expense 10.5m / Debt 1.31b)
Taxrate = 21.0% (US default 21%)
NOPAT = -177.9m (EBIT -225.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.54 (Total Current Assets 288.6m / Total Current Liabilities 63.6m)
Debt / Equity = -1.67 (negative equity) (Debt 1.31b / totalStockholderEquity, last quarter -784.1m)
Debt / EBITDA = -6.08 (negative EBITDA) (Net Debt 1.19b / EBITDA -196.3m)
Debt / FCF = -8.36 (negative FCF - burning cash) (Net Debt 1.19b / FCF TTM -142.9m)
Total Stockholder Equity = -678.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -36.78% (Net Income -237.7m / Total Assets 599.7m)
RoE = 35.06% (negative equity) (Net Income TTM -237.7m / Total Stockholder Equity -678.0m)
RoCE = -40.29% (EBIT -225.2m / Capital Employed (Equity -678.0m + L.T.Debt 1.24b))
RoIC = -35.53% (negative operating profit) (NOPAT -177.9m / Invested Capital 500.8m)
WACC = 2.66% (E(346.2m)/V(1.66b) * Re(10.34%) + D(1.31b)/V(1.66b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
Fair Price DCF = unknown (Cash Flow -142.9m)
EPS Correlation: 92.22 | EPS CAGR: 113.6% | SUE: 1.61 | # QB: 1
Revenue Correlation: -71.01 | Revenue CAGR: -9.16% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.09 | Chg30d=+0.308 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.48 | Chg30d=+0.922 | Revisions Net=+4 | Growth EPS=+55.5% | Growth Revenue=-1.5%